Ophthalmology and Vision Science

Corneal Diseases and Advanced Therapeutic Approaches

Corneal diseases, including keratoconus, infectious keratitis, and corneal dystrophies, significantly impact vision and quality of life, requiring timely diagnosis and management. Modern diagnostic tools such as corneal topography, pachymetry, anterior segment optical coherence tomography, and in vivo confocal microscopy allow precise assessment of corneal morphology and pathology. Therapeutic interventions range from pharmacological management with antibiotics, antivirals, and anti-inflammatory agents to surgical approaches such as corneal transplantation, keratoprosthesis, and corneal cross-linking. Challenges include managing refractory infections, post-surgical complications, and access to advanced care in resource-limited settings. Innovations in regenerative medicine, including stem cell therapy and tissue engineering, are being explored to restore corneal transparency and function. Nanotechnology-based drug delivery enhances targeted therapy while minimizing systemic side effects. Artificial intelligence aids in early detection, grading disease severity, and predicting treatment outcomes. Regulatory oversight ensures safety, efficacy, and quality standards for novel corneal implants, drugs, and surgical devices. Emerging trends focus on personalized treatment strategies, minimally invasive surgical techniques, and integration of digital imaging and tele-ophthalmology for remote monitoring. By combining clinical expertise, cutting-edge technology, and robust regulatory frameworks, advances in corneal disease management continue to improve visual outcomes and patient quality of life globally.